Doctor profile · Federal record
Dr. DANIEL WYNN, M.D.
Neurology Physician (CMS: NEUROLOGY) · Epilepsy Physician · Neurology Physician · Clinical Neurophysiology Physician · NORTHBROOK, IL
- NPI 1710971700
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 43 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1535 LAKE COOK RD, SUITE 601
NORTHBROOK, IL 600621447
(847) 509-0270
fax (847) 509-0273
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- February 5, 2025
- Year of graduation
- 1983 — 43 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State licenses (2)
- Illinois #036076784 · Illinois #036-076784
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1710971700. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,150
Distinct HCPCS
5
Medicare allowed
$115,182
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0585 |
Injection, onabotulinumtoxina, 1 unit | 4,500 | 12 | $0 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 493 | 253 | $185 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 78 | 54 | $132 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 53 | 53 | $232 | |
95806 |
Sleep study including heart rate, breathing, airflow, and effort | 26 | 23 | $45 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 627. This provider delivers 8.2× the peer median.Open Payments
Industry payments received
All-time total
$96,449
Transactions
220
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| EMD Serono, Inc. | 31 | $23,041.63 | |
| GENZYME CORPORATION | 17 | $19,318.07 | |
| Mallinckrodt Hospital Products Inc. | 22 | $17,534.69 | |
| TG Therapeutics, Inc. | 13 | $11,540.69 | |
| E.R. Squibb & Sons, L.L.C. | 10 | $8,814.66 | |
| Celgene Corporation | 32 | $7,514.77 | |
| Mylan Specialty L.P. | 4 | $2,750.37 | |
| Vanda Pharmaceuticals Inc. | 8 | $1,205.62 | |
| ABBVIE INC. | 24 | $527.91 | |
| MDD US Operations, LLC | 4 | $412.30 | |
| PFIZER INC. | 25 | $381.29 | |
| ARGENX US, INC. | 4 | $373.98 | |
| ANI Pharmaceuticals, Inc. | 7 | $290.16 | |
| UCB, Inc. | 8 | $247.07 | |
| Neurocrine Biosciences, Inc. | 11 | $246.94 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,571
Patients
375
Total drug cost
$4,995,987
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Baclofen | Generic | 198 | 52 | $7,342 |
| Dalfampridine Er (Dalfampridine) | Brand | 143 | 31 | $134,513 |
| Nuedexta (Dextromethorphan Hbr/Quinidine) | Brand | 124 | 21 | $318,242 |
| Aubagio (Teriflunomide) | Brand | 121 | 31 | $1,824,357 |
| Escitalopram Oxalate | Generic | 119 | 31 | $2,265 |
| Gabapentin | Generic | 113 | 34 | $2,782 |
| Rebif (Interferon Beta-1a/Albumin) | Brand | 107 | 13 | $1,351,099 |
| Copaxone (Glatiramer Acetate) | Brand | 93 | 14 | $779,410 |
| Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine) | Brand | 93 | 15 | $3,716 |
| Oxcarbazepine | Generic | 88 | 31 | $10,413 |